Tag Archives: cell

Health Care Industry Spends $30B A Year Pushing Its Wares, From Drugs To Stem Cell Treatment

Use Our Content This story can be republished for free (details). Hoping to earn its share of the $ 3.5 trillion health care market, the medical industry is pouring more money than ever into advertising its products — from high-priced prescriptions to do-it-yourself genetic tests and unapproved stem cell treatments. Spending on health care marketing… Read More »

Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK

Merck’s latest Keytruda approval isn’t necessarily a huge one for the New Jersey drugmaker when it comes to sales. But it’s a big deal for Pfizer and Merck KGaA, maker of rival drug Bavencio. Wednesday, the FDA green-lighted Merck’s immuno-oncology blockbuster in rare skin cancer Merkel cell carcinoma, an area where Bavencio had previously held… Read More »

FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy

Print this page NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted approval of Elzonris (tagraxofusp-erzs; SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)… Read More »